Cargando…
Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports
Medical products comprising human cells, genes, and tissues have been developed for clinical applications worldwide, and their developmental environment has been established. These products can be imported and exported, but marketing authorization regulations are complicated among regions. This inve...
Autores principales: | Kurauchi, Ryosuke, Kasai, Hiroi, Ito, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785882/ https://www.ncbi.nlm.nih.gov/pubmed/33425872 http://dx.doi.org/10.3389/fbioe.2020.606606 |
Ejemplares similares
-
New genomic techniques and their European Union reform. Potential policy changes and their implications
por: Zimny, Tomasz
Publicado: (2022) -
Recovering the Original Intentions of Risk Assessment and Management of Genetically Modified Organisms in the European Union
por: Eriksson, Dennis
Publicado: (2018) -
3D Microfluidic Bone Tumor Microenvironment Comprised of Hydroxyapatite/Fibrin Composite
por: Ahn, Jungho, et al.
Publicado: (2019) -
Temporary Storage of the Human Nasal Tissue and Cell Sheet for Wound Repair
por: Kasai, Yoshiyuki, et al.
Publicado: (2021) -
Recent Progress in European Advanced Therapy Medicinal Products and Beyond
por: Yu, Tracy T. L., et al.
Publicado: (2018)